When treated with DKN-01 followed by CGX-1321, known as Sequential Wnt modulation, a variety of leukocytes are recruited into the tumor microenvironment by modulating Wnt signaling, including B cells and macrophages in addition to CD8+ T cells.131. Here, CD8A is linked to neoplasm.